Trials / Completed
CompletedNCT00839696
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- Female
- Age
- 55 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.
Conditions
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2009-06-01
- Completion
- 2010-04-01
- First posted
- 2009-02-09
- Last updated
- 2019-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00839696. Inclusion in this directory is not an endorsement.